Gene expression in hypothalamus, liver, and adipose tissues and food intake response to melanocortin-4 receptor agonist in pigs expressing melanocortin-4 receptor mutations.
Barb. C Richard CR; Hausman. Gary J GJ; Rekaya. Romdhane R; Lents. Clay A CA; Lkhagvadorj. Sender S; Qu. L L; Cai. W W; Couture. Oliver P OP; Anderson. Lloyd L LL; Dekkers. Jack C M JC; Tuggle. Christopher K CK
Key Findings
- NDP‑MSH sharply cut food intake at 12 h and 24 h in all pigs studied
- In liver and fat, genes for making steroids, lipids, fatty acids and amino acids were turned down, while genes for oxidative phosphorylation were turned up
- The overall pattern points to a metabolic switch that conserves energy rather than building new tissue
Practical Outcomes
- The data confirm that activating MC4R can suppress appetite and shift metabolism, which is interesting for weight‑control strategies. However, the peptide was delivered directly into the brain in pigs, a route not practical for humans, so no concrete dosing or protocol can be recommended yet. More human‑focused research is needed before biohackers can safely apply MC4R agonists for longevity or performance.
Summary
A brain‑injected MC4R‑activating peptide called NDP‑MSH made pigs eat less and changed many genes in their brain, liver and fat, pushing the body toward using existing energy rather than building new molecules. The effects were seen in all pig groups, regardless of their MC4R genetic variant.
Abstract
Transcriptional profiling was used to identify genes and pathways that responded to intracerebroventricular injection of melanocortin-4 receptor (MC4R) agonist [Nle(4), d-Phe(7)]-α-melanocyte stimulating hormone (NDP-MSH) in pigs homozygous for the missense mutation in the MC4R, D298 allele (n = 12), N298 allele (n = 12), or heterozygous (n = 12). Food intake (FI) was measured at 12 and 24 h after treatment. All pigs were killed at 24 h after treatment, and hypothalamus, liver, and back-fat tissue was collected. NDP-MSH suppressed (P < 0.004) FI at 12 and 24 h in all animals after treatment. In response to NDP-MSH, 278 genes in hypothalamus (q ≤ 0.07, P ≤ 0.001), 249 genes in liver (q ≤ 0.07, P ≤ 0.001), and 5,066 genes in fat (q ≤ 0.07, P ≤ 0.015) were differentially expressed. Pathway analysis of NDP-MSH-induced differentially expressed genes indicated that genes involved in cell communication, nucleotide metabolism, and signal transduction were prominently downregulated in the hypothalamus. In both liver and adipose tissue, energy-intensive biosynthetic and catabolic processes were downregulated in response to NDP-MSH. This included genes encoding for biosynthetic pathways such as steroid and lipid biosynthesis, fatty acid synthesis, and amino acid synthesis. Genes involved in direct energy-generating processes, such as oxidative phosphorylation, electron transport, and ATP synthesis, were upregulated, whereas TCA-associated genes were prominently downregulated in NDP-MSH-treated pigs. Our data also indicate a metabolic switch toward energy conservation since genes involved in energy-intensive biosynthetic and catabolic processes were downregulated in NDP-MSH-treated pigs.
Study Information
pubmed
2010
2010-03-09T00:00:00.000Z
10.1152/physiolgenomics.00006.2010
16
77